mRNA vaccines for SARS-CoV-2 have been authorized for emergency use. Despite their
efficacy in clinical trials, data on mRNA vaccine–induced immune responses are mostly limited …

Although critical illness has been associated with SARS-CoV-2–induced hyperinflammation,
the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively …

Genomic DNA is often thought of as the stable template of heredity, largely dormant and
unchanging, apart from perhaps the occasional point mutation. But it has become increasingly …

Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell product targeting CD19 is approved
for relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, the impact …

… Regarding CD8 + T cell responses, our AIM assay was effective at capturing peak … sensitive
enough to detect very low-frequency CD8 + T cells at memory time points. Other approaches, …

Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate platelet
destruction and inhibit their production. Most cases are considered idiopathic, whereas …

COVID-19 is associated with a wide range of clinical manifestations, including autoimmune
features and autoantibody production. Here we develop three protein arrays to measure IgG …

SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …

Adjuvants are critical for improving the quality and magnitude of adaptive immune responses
to vaccination. Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA …

L1 retrotransposons are autonomous retroelements that are active in the human and mouse
genomes. Previously, we developed a cultured cell assay that uses a neomycin …